The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
Open accessAbstract
The management of the central nervous system (CNS) disorders is challenging, due to the need of drugs to cross the blood‒brain barrier (BBB) and reach the brain. Among the various strategies that have been studied to circumvent this challenge, the use of the intranasal route to transport drugs from the nose directly to the brain has been showing promising results. In addition, the encapsulation of the drugs in lipid-based nanocarriers, such as solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs) or nanoemulsions (NEs), can improve nose-to-brain transport by increasing the bioavailability and site-specific delivery. This review provides the state-of-the-art of in vivo studies with lipid-based nanocarriers (SLNs, NLCs and NEs) for nose-to-brain delivery. Based on the literature available from the past two years, we present an insight into the different mechanisms that drugs can follow to reach the brain after intranasal administration. The results of pharmacokinetic and pharmacodynamics studies are reported and a critical analysis of the differences between the anatomy of the nasal cavity of the different animal species used in in vivo studies is carried out. Although the exact mechanism of drug transport from the nose to the brain is not fully understood and its effectiveness in humans is unclear, it appears that the intranasal route together with the use of NLCs, SLNs or NEs is advantageous for targeting drugs to the brain. These systems have been shown to be more effective for nose-to-brain delivery than other routes or formulations with non-encapsulated drugs, so they are expected to be approved by regulatory authorities in the coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Ahmad, N., Ahmad, R., Naqvi, A. A., Alam, A., Ashafaq, M., Rub, R. A., & Ahmad, F. J. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1337024 · Cited by 76
RetractedGadhave, D. G., Tagalpallewar, A. A., & Kokare, C. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-018-1213-y · Cited by 49
RetractedAhmad, N., Ahmad, R., Alam, M. A., Ahmad, F. J., & Amir, M. (2018) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2018.1489826 · Cited by 46
RetractedDanaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Mohammadi-Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 970
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases
Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.022 · Cited by 731
Mechanism of intranasal drug delivery directly to the brain
Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G., & Hsu, W. H. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.025 · Cited by 721
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
Das, S., Ng, W. K., & Tan, R. B. H. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.05.010 · Cited by 576
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.017 · Cited by 569
Tapeinos, C., Battaglini, M., & Ciofani, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.033 · Cited by 539
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
Haider, M., Abdin, S. M., Kamal, L., & Orive, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030288 · Cited by 451
Gänger, S., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030116 · Cited by 447
Progress in brain targeting drug delivery system by nasal route
Khan, A. R., Liu, M., Khan, M. W., & Zhai, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.001 · Cited by 402
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Battaglia, L., & Gallarate, M. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.673278 · Cited by 400
Garcês, A., Amaral, M. H., Sousa Lobo, J. M., & Silva, A. C. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.023 · Cited by 396
Self-citationNanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Ragelle, H., Danhier, F., Préat, V., Langer, R., & Anderson, D. G. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1244187 · Cited by 390
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
The biopharmaceutical aspects of nasal mucoadhesive drug delivery
Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775145 · Cited by 355
Quantitative analysis of drug delivery to the brain via nasal route
Kozlovskaya, L., Abou-Kaoud, M., & Stepensky, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.053 · Cited by 337
Djupesland, P. G., Messina, J. C., & Mahmoud, R. A. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.41 · Cited by 295
Nasal Drug Administration: Potential for Targeted Central Nervous System Delivery
Graff, C. L., & Pollack, G. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20318 · Cited by 260
Muntimadugu, E., Dhommati, R., Jain, A., Challa, V. G. S., Shaheen, M., & Khan, W. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.012 · Cited by 240
Wang, Z., Xiong, G., Tsang, W. C., Schätzlein, A. G., & Uchegbu, I. F. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258152 · Cited by 231
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Pires, P. C., & Santos, A. O. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.047 · Cited by 228
Selvaraj, K., Gowthamarajan, K., & Karri, V. V. S. R. (2017) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2017.1420073 · Cited by 210
Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis
Costa, C., Moreira, J. N., Amaral, M. H., Sousa Lobo, J. M., & Silva, A. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.049 · Cited by 210
Self-citationPharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems
Glassman, P. M., & Muzykantov, V. R. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257113 · Cited by 209
Evidence of nose-to-brain delivery of nanoemulsions: Cargoes but not vehicles
Ahmad, E., Feng, Y., Qi, J., Fan, W., Ma, Y., He, H., Xia, F., Dong, X., Zhao, W., Lu, Y., et al. (2017) · Nanoscale · doi:10.1039/c6nr07581a · Cited by 194
Johnson, N. J., Hanson, L. R., & Frey, W. H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100029t · Cited by 194
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 184
Gaba, B., Khan, T., Haider, M. F., Alam, T., Baboota, S., Parvez, S., & Ali, J. (2019) · BioMed Research International · doi:10.1155/2019/2382563 · Cited by 180
Djupesland, P. G., & Skretting, A. (2012) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2011.0924 · Cited by 170
Cunha, S., Costa, C. P., Loureiro, J. A., Alves, J., Peixoto, A. F. R. O., Forbes, B., Lobo, J. M. S., & Silva, A. C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070599 · Cited by 156
Self-citationYoussef, N. A. H. A., Kassem, A. A., Farid, R. M., Ismail, F. A., EL-Massik, M. A. E., & Boraie, N. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.014 · Cited by 153
Breath Actuated Device Improves Delivery to Target Sites Beyond the Nasal Valve
Djupesland, P. G., Skretting, A., Winderen, M., & Holand, T. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000199741.08517.99 · Cited by 146
Chamanza, R., & WRIGHT, J. A. (2015) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2015.08.009 · Cited by 146
Lipid Nanoparticles for Nasal/Intranasal Drug Delivery
Cunha, S., Amaral, M. H., Lobo, J. M. S., & Silva, A. C. (2017) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2017018693 · Cited by 138
Self-citationRuigrok, M. J. R., & de Lange, E. C. M. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9724-x · Cited by 137
Cunha, S., Costa, C. P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102206 · Cited by 136
Self-citationPietrowsky, R., Strüben, C., Mölle, M., Fehm, H. L., & Jan Born, A. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00180-8 · Cited by 133
Shirodkar, R. K., Kumar, L., Mutalik, S., & Lewis, S. A. (2019) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-019-02017-9 · Cited by 132
Potential of Nanoparticulate Drug Delivery Systems by Intranasal Administration
Ali, J., Ali, M., Baboota, S., Sahni, J. K., Ramassamy, C., Dao, L. H., & Bhavna (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791164108 · Cited by 130
Gadhave, D. G., & Kokare, C. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1576724 · Cited by 120
Rajput, A., & Butani, S. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.01.040 · Cited by 120
Jazuli, I., Annu, Nabi, B., Moolakkadath, T., Alam, T., Baboota, S., & Ali, J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.001 · Cited by 117
Formulation and device design to increase nose to brain drug delivery
Warnken, Z. N., Smyth, H. D. C., Watts, A. B., Weitman, S., Kuhn, J. G., & Williams, R. O. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.05.003 · Cited by 114
Jojo, G. M., Kuppusamy, G., De, A., & Karri, V. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1593439 · Cited by 111
Lipid Nano- and Microparticles: An Overview of Patent-Related Research
Battaglia, L., & Ugazio, E. (2019) · Journal of Nanomaterials · doi:10.1155/2019/2834941 · Cited by 103
Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges
Karami, Z., Zanjani, M. R. S., & Hamidi, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.021 · Cited by 103
Lipid-based nanoformulations in the treatment of neurological disorders
Pottoo, F. H., Sharma, S., Javed, M. N., Barkat, M. A., Harshita, Alam, M. S., Naim, M. J., Alam, O., Ansari, M. A., Barreto, G. E., et al. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1726942 · Cited by 98
Lipid nanoparticles: perspectives and challenges☆
Gasco, M. R. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.004 · Cited by 96
Sabir, F., Ismail, R., & Csóka, I. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.10.005 · Cited by 91
Abbas, H., Refai, H., & Sayed, N. S. E. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.04.007 · Cited by 84
Singh, S. K., Hidau, M. K., Gautam, S., Gupta, K., Singh, K. P., Singh, S. K., & Singh, S. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.031 · Cited by 76
Kumar, S., Dang, S., Nigam, K., Ali, J., & Baboota, S. (2018) · Rejuvenation Research · doi:10.1089/rej.2017.2035 · Cited by 72
Jiang, Y., Liu, C., Zhai, W., Zhuang, N., Han, T., & Ding, Z. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s214657 · Cited by 71
Brain–blood ratio: implications in brain drug delivery
Kulkarni, A. D., Patel, H., Surana, S. J., Belgamwar, V. S., & Pardeshi, C. V. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1092519 · Cited by 65
Pardeshi, C. V., & Belgamwar, V. S. (2019) · Materials Technology · doi:10.1080/10667857.2019.1674522 · Cited by 62
Yasir, M., Sara, U. V. S., Chauhan, I., Gaur, P. K., Singh, A. P., Puri, D., & Ameeduzzafar (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1394872 · Cited by 61
Arora, A., Kumar, S., Ali, J., & Baboota, S. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104917 · Cited by 60
Patel, R. J., & Parikh, R. H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119486 · Cited by 60
Du, W., Li, H., Tian, B., Sai, S., Gao, Y., Lan, T., Meng, Y., & Ding, C. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110446 · Cited by 55
Intranasal angiotensin II directly influences central nervous regulation of blood pressure
Derad, I., Willeke, K., Pietrowsky, R., Jan Born, A., & Fehm, H. L. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00095-8 · Cited by 43
Alavian, F., & Shams, N. (2019) · Current Clinical Pharmacology · doi:10.2174/1574884714666190704115345 · Cited by 40
Silva, A. C., González‐Mira, E., Lobo, J. M. S., & Amaral, M. H. (2013) · Current Pharmaceutical Design · doi:10.2174/138161281941131219123329 · Cited by 34
Self-citationIn Situ and Ex Vivo Nasal Models for Preclinical Drug Development Studies
Agu, R. U., & Ugwoke, M. I. (2007) · Springer eBooks · doi:10.1007/978-0-387-74901-3_5 · Cited by 31
The nasal cavity of the sheep and its olfactory sensory epithelium
Barrios, A. W., Sánchez‐Quinteiro, P., & Salazar, I. (2014) · Microscopy Research and Technique · doi:10.1002/jemt.22436 · Cited by 30
Turfus, S. C., Delgoda, R., Picking, D., & Gurley, B. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802104-0.00025-1 · Cited by 24
Shobo, A., Pamreddy, A., Kruger, H. G., Makatini, M. M., Naicker, T., Govender, T., & Baijnath, S. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0365 · Cited by 23
The Role of Pharmacokinetics and Pharmacodynamics in the Development of Biotech Drugs
Meibohm, B. (2006) · doi:10.1002/9783527609628.ch1 · Cited by 17
Cited by
Ndeupen, S., Qin, Z., Jacobsen, S., Bouteau, A., Estanbouli, H., & Igyártó, B. Z. (2021) · iScience · doi:10.1016/j.isci.2021.103479 · Cited by 678
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J. L., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s447496 · Cited by 365
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
Formica, M. L., Real, D. A., Picchio, M. L., Catlin, E., Donnelly, R. F., & Paredes, A. J. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101631 · Cited by 282
Metadata
- Authors
- Costa, C. P., Moreira, J. N., Sousa Lobo, J. M., & Silva, A. C.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 11
- Issue
- 4
- Pages
- 925-940
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3138364107
- Cited by
- 303
- References
- 84
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.